InvestorsHub Logo
Followers 188
Posts 29071
Boards Moderated 1
Alias Born 08/29/2012

Re: BostonTrader post# 182900

Monday, 02/08/2016 1:37:20 PM

Monday, February 08, 2016 1:37:20 PM

Post# of 404305
ELTP
Successful formulation/technology: COMPLETE

Pivotal BE Study: COMPLETE

Registration batches: 6- mos ACC, 24- mos CRT: COMPLETE

Lab Abuse Study: COMPLETE

Liking Study, Intranasal: COMPLETE

Fed Study: Dosing COMPLETE

Withdrawal Study: Dosing COMPLETE

Efficacy Study: Dosing COMPLETE

Pediatric Study: Post product launch

FDA filing fee waiver: Recieved

Elite's First Art NDA Filing- ELI 200: COMPLETE

FDA NDA Acceptance: Imminent

NDA Expedited Review: Imminent

Two Generic launches: Imminent

Guidance for ELI-201 and 202: Imminent

ELI-200 Launch: Scheduled for 2016

You Can Tell A Man's Character By The Way He Treats Those Who Can Do Nothing For Him

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ELTP News